Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.1K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.4K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput measurements of protein domain functions using magnetic separation.

Nature protocols·2026
Same author

An image-based CRISPR screen reveals splicing-mediated control of HP1α condensates.

bioRxiv : the preprint server for biology·2026
Same author

Programmable synthetic cytokine receptors polarize macrophages to user-defined functional states.

bioRxiv : the preprint server for biology·2026
Same author

Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotype.

bioRxiv : the preprint server for biology·2026
Same author

Tuberculosis: So much accomplished and so much more to be done.

The Indian journal of medical research·2026
Same author

Asymptomatic Tuberculosis Across the Disease Spectrum: A Scoping Review of Epidemiology, Diagnosis, and Public Health Implications.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Mapping the path to clinical implementation of multi-omics.

Nature genetics·2026
Same journal

Toward a framework for measuring the impact of ELSI research.

Nature genetics·2026
Same journal

Mutational scanning reveals substrate-assisted autoregulation of the WNT destruction complex.

Nature genetics·2026
Same journal

Spatial transcriptomic analyses highlight distinct erythroid niches in mice and humans.

Nature genetics·2026
Same journal

Building up pangenome analysis block by block.

Nature genetics·2026
Same journal

Mutations in splicing factor gene U2AF1 rescue defective oncogene splicing in KRAS-mutant cancers.

Nature genetics·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K

Finding host targets for HIV therapy.

C Kimberly Tsui1, Amita Gupta1, Michael C Bassik1

  • 1Departments of Genetics and Chemistry, Engineering and Medicine for Human Health (ChEM-H), Stanford University, Stanford, California, USA.

Nature Genetics
|February 1, 2017
PubMed
Summary
This summary is machine-generated.

A CRISPR screen revealed host factors crucial for HIV infection in CD4+ T cells. These factors, including CCR5 sulfation and cell aggregation, are potential therapeutic targets for HIV treatment.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.3K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K

Related Experiment Videos

Last Updated: Mar 8, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.3K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Human Immunodeficiency Virus (HIV) infects CD4+ T cells, leading to Acquired Immunodeficiency Syndrome (AIDS).
  • Understanding host factors essential for HIV replication is critical for developing effective antiviral therapies.

Purpose of the Study:

  • To identify host cellular factors required for HIV infection using a CRISPR screening approach.
  • To uncover novel therapeutic targets for HIV intervention by analyzing essential host factors.

Main Methods:

  • Conducted a CRISPR-based genetic screen in a CD4+ T cell leukemia line.
  • Assessed the impact of gene knockouts on HIV infectivity and cell survival.

Main Results:

  • Identified specific host factors indispensable for HIV infection but not for cell viability.
  • Highlighted the role of sulfation on the HIV co-receptor CCR5 in viral entry.
  • Demonstrated the significance of cellular aggregation in the HIV lifecycle.

Conclusions:

  • Host factors identified represent promising targets for novel anti-HIV therapeutics.
  • Targeting CCR5 sulfation or cellular aggregation could inhibit HIV infection with minimal impact on host cell function.